CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 240 enrolled
Drug / intervention
packagingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01744977
NCT01744977N/ACompleted

Evaluate the Efficacy, Perceptions and Cost of an Innovative Cholesterol Packaging

Durham VA Medical Center·interventional·Posted Dec 7, 2012·Updated May 18, 2016

In Brief

A clinical study evaluating packaging for Hypercholesterolemia. Completed, enrolled 240 participants across 2 sites.

Detailed Summary

The purpose of the overall study is to improve medication use rates among veterans by looking at the risk factors of low-density lipoprotein cholesterol (LDL). It will involve patients who have high LDL-C level (\<130mg/dl) and /or may have difficulty taking their medications based on how often they refilled their medications in the last 12 months. The investigators will test an innovative adherence packaging relative to usual care. The primary hypothesis is that veterans who receive the intervention will have greater improvement in their medication adherence as measured by pill refill at 6 and 12 months of follow up as compared to the control group.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedDec 7, 2012
Enrollment StartDec 1, 2012
Primary CompletionMay 1, 2015
Study CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 13.6 years ago

Interventions

packagingbehavioral

Intervention provides usual statin medication dispensed in pre-prepared adherence packaging (blister packaging) rather than the previously received prescription bottles